AU2668897A - Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents - Google Patents

Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents

Info

Publication number
AU2668897A
AU2668897A AU26688/97A AU2668897A AU2668897A AU 2668897 A AU2668897 A AU 2668897A AU 26688/97 A AU26688/97 A AU 26688/97A AU 2668897 A AU2668897 A AU 2668897A AU 2668897 A AU2668897 A AU 2668897A
Authority
AU
Australia
Prior art keywords
adenoviruses
gene therapy
immunosuppressive agents
repeated administration
therapy involving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26688/97A
Inventor
Michael Kaleko
Alan Mcclelland
Theodore Smith
Bruce C. Trapnell
Soonpin Yei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetic Therapy Inc
Original Assignee
Genetic Therapy Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Therapy Inc filed Critical Genetic Therapy Inc
Publication of AU2668897A publication Critical patent/AU2668897A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU26688/97A 1996-04-19 1997-04-15 Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents Abandoned AU2668897A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63477496A 1996-04-19 1996-04-19
US08634774 1996-04-19
PCT/US1997/006199 WO1997039776A1 (en) 1996-04-19 1997-04-15 Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents

Publications (1)

Publication Number Publication Date
AU2668897A true AU2668897A (en) 1997-11-12

Family

ID=24545153

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26688/97A Abandoned AU2668897A (en) 1996-04-19 1997-04-15 Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents

Country Status (2)

Country Link
AU (1) AU2668897A (en)
WO (1) WO1997039776A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19711803A1 (en) * 1997-03-21 1998-09-24 Hoechst Ag Extension of expression of transgenic proteins by immunomodulating treatment with 15-deoxyspergualin
AU3883299A (en) * 1998-05-12 1999-11-29 Baylor College Of Medicine Cancer prevention by selective delivery methods
AU5470900A (en) * 1999-06-08 2000-12-28 Children's Hospital Of Philadelphia, The Methods for preventing formation of inhibitory antibodies in the setting of genetherapy
US20020014242A1 (en) 2000-07-31 2002-02-07 Abraham Scaria Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products
CA3103740A1 (en) 2018-06-29 2020-01-02 Wuhan Neurophth Biotechnology Limited Company Compositions and methods for treating leber's hereditary optic neuropathy
CA3109432A1 (en) 2018-08-20 2020-02-27 Wuhan Neurophth Biotechnology Limited Company Compositions and methods for treating leber's hereditary optic neuropathy
CN113025633B (en) 2019-12-09 2024-08-27 武汉纽福斯生物科技有限公司 Nucleic acid for encoding human NADH dehydrogenase subunit 1 protein and application thereof

Also Published As

Publication number Publication date
WO1997039776A1 (en) 1997-10-30

Similar Documents

Publication Publication Date Title
EP0804076A4 (en) Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents
PL330814A1 (en) Compounds for and methods of delivering pharmaceutical preparations and their application
AUPN698495A0 (en) Improved therapeutic formulation and method
AU5136093A (en) Peptide antagonists of sh2 binding and therapeutic uses thereof
AU1403199A (en) Local delivery of therapeutic agents
AU3844597A (en) Peptides for treatment of inflammation and shock
AU3171997A (en) Cosmetic and/or pharmaceutical preparations
AU1616499A (en) Chemokine variants and methods of use
AU4803997A (en) Polymorphisms and new genes in the region of the human hemochromatosis gene
AU1842597A (en) Human rad50 and septin-2 genes and methods of use
AU2668897A (en) Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents
AU7378498A (en) Hybrid ribozymes and methods of use
AU3118297A (en) Sok-1 and methods of use
AU2408397A (en) Ob protein receptor genes and use of the same
AU6582698A (en) Therapeutic uses of grip and grip-related molecules
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
AU2512495A (en) Therapeutic phenoxyalkylazoles and phenoxyalkylazines
AU8750198A (en) Antibiotic preparations and use of the same
AU4994596A (en) Interdependent adenoviral vectors and methods of using same
AU1856297A (en) Lyst1 and lyst2 gene compositions and methods of use
EP0959887A4 (en) Pharmaceutically active compounds and methods of use
AU6653698A (en) Use of the p-ten suppressor gene in diagnosis and treatment of cancer
AU5697996A (en) Peptidyl compounds and their therapeutic use
AU9358398A (en) Use of p-glycoprotein (pgp) inhibitors in the treatment of cancer
AU3053595A (en) Therapeutic treatment and preparations